Blue Bell Private Wealth Management, LLC Crispr Therapeutics Ag Transaction History
Blue Bell Private Wealth Management, LLC
- $460 Million
- Q2 2024
A detailed history of Blue Bell Private Wealth Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Blue Bell Private Wealth Management, LLC holds 207 shares of CRSP stock, worth $10,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
207
Previous 132
56.82%
Holding current value
$10,265
Previous $8,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$390 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$386 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$156 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$156 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$138 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.87B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....